European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001)

被引:16
作者
Gandjour, A
Kleinschmit, F
Lauterbach, KW
机构
[1] Johanniter Hosp, Dept Med 1, Duisburg, Germany
[2] Univ Cologne, Inst Gesundheitsokon & Klin Epidemiol, D-50935 Cologne, Germany
[3] Univ York, Ctr Hlth Econ, Michael Drummond, York YO1 5DD, N Yorkshire, England
关键词
myocardial infarction; quality; costs; Europe;
D O I
10.1053/euhj.2001.3080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To compare the inpatient costs and process quality in the treatment of acute myocardial infarction in France. Germany, Italy. The Netherlands, Sweden. Switzerland. and the U.K. Methods A total of 208 European hospitals assessed cervices for one hypothetical average patient with acute myocardial infarction (cost evaluation) and prospectively followed up one or two real acute myocardial infarction patients (quality evaluation) in 2000/2001. The following cost modules were evaluated: general medicine ward. critical care unit (both personnel costs only), and reperfusion therapy. The following process quality indicators were evaluated: reperfusion therapy: and prescription of aspirin. lidocaine. beta-blockers. and ACE inhibitors. Results Switzerland, Germany. and France had the highest reperfusion costs due to a relatively high percentage of patients receiving percutaneous transluminal coronary angioplasties. stents. and glycoprotein IIb/IIIa blockers. Personnel costs for general medicine wards and critical care units were highest in Italy and Germany due to relatively long hospital stays. Average quality ratings ranged from 89% in the U.K. and France to 96% in Germany. Conclusion There was little variation in the process quality of care for treating acute myocardial infarction, Differences in resource use may result from differences in the types of reimbursement and in the rates of diffusion of new technology. (C) 2002 The European Society of Cardiology, Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:858 / 868
页数:11
相关论文
共 32 条
[1]   Evidence of self-report bias in assessing adherence to guidelines [J].
Adams, AS ;
Soumerai, SB ;
Lomas, J ;
Ross-Degnan, D .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 1999, 11 (03) :187-192
[2]  
Allison J J, 2000, Jt Comm J Qual Improv, V26, P115
[3]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[4]  
[Anonymous], 1997, Eur Heart J, V18, P1569
[5]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[6]  
Baxter C, 1998, BMJ-BRIT MED J, V317, P1134
[7]  
*BRIT MED ASS ROYA, 2000, BRIT NAT FORM
[8]   Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction - A meta-analysis of randomized clinical trials [J].
Domanski, MJ ;
Exner, DV ;
Borkowf, CB ;
Geller, NL ;
Rosenberg, Y ;
Pfeffer, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :598-604
[9]  
Donabedian A., 1980, EXPLORATIONS QUALITY
[10]   Performance measurement: Problems and solutions [J].
Eddy, DM .
HEALTH AFFAIRS, 1998, 17 (04) :7-25